Your browser doesn't support javascript.
loading
Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study.
Regan, Elizabeth A; Lowe, Melissa E; Make, Barry J; Curtis, Jeffrey L; Chen, Quan Grace; Cho, Michael H; Crooks, James L; Lowe, Katherine E; Wilson, Carla; O'Brien, James K; Oates, Gabriela R; Baldomero, Arianne K; Kinney, Gregory L; Young, Kendra A; Diaz, Alejandro A; Bhatt, Surya P; McCormack, Meredith C; Hansel, Nadia N; Kim, Victor; Richmond, Nicole E; Westney, Gloria E; Foreman, Marilyn G; Conrad, Douglas J; DeMeo, Dawn L; Hoth, Karin F; Amaza, Hannatu; Balasubramanian, Aparna; Kallet, Julia; Watts, Shandi; Hanania, Nicola A; Hokanson, John; Beaty, Terri H; Crapo, James D; Silverman, Edwin K; Casaburi, Richard; Wise, Robert.
Afiliação
  • Regan EA; Department of Medicine, National Jewish Health, Denver, CO, USA. Regane@NJHealth.org.
  • Lowe ME; Duke Cancer Center, Biostatistics, Duke University Medical Center, Durham, NC, USA.
  • Make BJ; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Curtis JL; Pulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, MI, USA.
  • Chen QG; Pulmonary & Critical Care Medicine Section, Veterans Affairs Medical Center, Ann Arbor, MI, USA.
  • Cho MH; Edwards Lifesciences, Irvine, CA, USA.
  • Crooks JL; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Lowe KE; Division of Biostatistics and Bioinformatics and Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO, USA.
  • Wilson C; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
  • O'Brien JK; Cleveland Clinic Lerner College of Medicine of Case Western Reserve School of Medicine, Cleveland, OH, USA.
  • Oates GR; Research Informatics Services, National Jewish Health, Denver, CO, USA.
  • Baldomero AK; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Kinney GL; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Young KA; Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Diaz AA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
  • Bhatt SP; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
  • McCormack MC; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Hansel NN; Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Kim V; Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Richmond NE; Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Westney GE; Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USA.
  • Foreman MG; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
  • Conrad DJ; Pulmonary and Critical Care Medicine, Morehouse School of Medicine, Atlanta, GA, USA.
  • DeMeo DL; Pulmonary and Critical Care Medicine, Morehouse School of Medicine, Atlanta, GA, USA.
  • Hoth KF; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Amaza H; Department of Medicine, Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
  • Balasubramanian A; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • Kallet J; Iowa Neuroscience Institute, University of Iowa, Iowa City, IA, USA.
  • Watts S; Department of Psychiatry, University of Iowa, Iowa City, IA, USA.
  • Hanania NA; Pulmonary and Critical Care, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Hokanson J; Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Beaty TH; Department of Medicine, National Jewish Health, Denver, CO, USA.
  • Crapo JD; Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Silverman EK; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA.
  • Casaburi R; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Wise R; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO, USA.
J Gen Intern Med ; 38(13): 2988-2997, 2023 10.
Article em En | MEDLINE | ID: mdl-37072532
ABSTRACT

BACKGROUND:

COPD diagnosis is tightly linked to the fixed-ratio spirometry criteria of FEV1/FVC < 0.7. African-Americans are less often diagnosed with COPD.

OBJECTIVE:

Compare COPD diagnosis by fixed-ratio with findings and outcomes by race.

DESIGN:

Genetic Epidemiology of COPD (COPDGene) (2007-present), cross-sectional comparing non-Hispanic white (NHW) and African-American (AA) participants for COPD diagnosis, manifestations, and outcomes.

SETTING:

Multicenter, longitudinal US cohort study.

PARTICIPANTS:

Current or former smokers with ≥ 10-pack-year smoking history enrolled at 21 clinical centers including over-sampling of participants with known COPD and AA. Exclusions were pre-existing non-COPD lung disease, except for a history of asthma. MEASUREMENTS Subject diagnosis by conventional criteria. Mortality, imaging, respiratory symptoms, function, and socioeconomic characteristics, including area deprivation index (ADI). Matched analysis (age, sex, and smoking status) of AA vs. NHW within participants without diagnosed COPD (GOLD 0; FEV1 ≥ 80% predicted and FEV1/FVC ≥ 0.7).

RESULTS:

Using the fixed ratio, 70% of AA (n = 3366) were classified as non-COPD, versus 49% of NHW (n = 6766). AA smokers were younger (55 vs. 62 years), more often current smoking (80% vs. 39%), with fewer pack-years but similar 12-year mortality. Density distribution plots for FEV1 and FVC raw spirometry values showed disproportionate reductions in FVC relative to FEV1 in AA that systematically led to higher ratios. The matched analysis demonstrated GOLD 0 AA had greater symptoms, worse DLCO, spirometry, BODE scores (1.03 vs 0.54, p < 0.0001), and greater deprivation than NHW.

LIMITATIONS:

Lack of an alternative diagnostic metric for comparison.

CONCLUSIONS:

The fixed-ratio spirometric criteria for COPD underdiagnosed potential COPD in AA participants when compared to broader diagnostic criteria. Disproportionate reductions in FVC relative to FEV1 leading to higher FEV1/FVC were identified in these participants and associated with deprivation. Broader diagnostic criteria for COPD are needed to identify the disease across all populations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica Idioma: En Ano de publicação: 2023 Tipo de documento: Article